Related Experiment Video
Updated: May 31, 2025
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
31.8K
Challenges in treating patients with comorbid asthma and bronchiectasis
Mario Cazzola1, Luigino Calzetta2, Maria Gabriella Matera3
1Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy.
Respiratory Medicine
|January 23, 2025
Summary
Managing overlapping asthma and bronchiectasis needs personalized care. Inhaled corticosteroids require monitoring for infection risk, while therapies like macrolides and triple therapy show promise but need more research.
Area of Science:
- Pulmonology
- Respiratory Medicine
- Clinical Management
Background:
- Asthma and bronchiectasis frequently coexist, presenting complex management challenges.
- Current treatment strategies require careful consideration of individual patient profiles and potential medication side effects.
Purpose of the Study:
- To outline a tailored management approach for patients with overlapping asthma and bronchiectasis.
- To review current and potential therapeutic options, including inhaled corticosteroids, macrolides, LTRAs, and triple therapy.
Main Methods:
- Comprehensive clinical assessment of asthma severity and bronchiectasis extent.
- Evaluation of inhaled corticosteroids (ICS), macrolides, leukotriene receptor antagonists (LTRAs), and long-acting muscarinic antagonists (LAMA)/long-acting beta-agonists (LABA) therapies.
- Consideration of preventive measures like vaccination and sputum cultures.
Main Results:
- Inhaled corticosteroids (ICS) are common but necessitate monitoring for infection risk; dose reduction may be possible if stable.
- Adjunctive therapies like macrolides and LTRAs (used cautiously) may offer benefits.
- Triple therapy (ICS/LABA/LAMA) shows potential for bronchodilation and inflammation reduction, though RCT evidence in bronchiectasis is pending.
Conclusions:
- Personalized management integrating careful medication selection and monitoring is crucial.
- Preventive strategies are vital for minimizing infection risk.
- Further randomized controlled trials (RCTs) are needed to confirm the efficacy of advanced therapies, including triple therapy, in this patient population.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
176
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
176
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:24Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:22Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
01:24Cystic Fibrosis: Management
139
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
139